Globe Life (NYSE:GL) CFO Sells $3,781,260.00 in Stock

Globe Life Inc. (NYSE:GL) CFO Thomas Peter Kalmbach sold 21,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 30th. The stock was sold at an average price of $180.06, for a total transaction of $3,781,260.00. Following the sale, the chief financial officer owned 50,568 shares in the company, valued at approximately $9,105,274.08. The trade was a 29.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Thomas Peter Kalmbach also recently made the following trade(s):

• On Tuesday, July 28th, Thomas Peter Kalmbach sold 25,650 shares of Globe Life stock. The stock was sold at an average price of $178.58, for a total transaction of $4,580,577.00.
• On Friday, May 22nd, Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock. The stock was sold at an average price of $156.59, for a total transaction of $1,242,698.24.
• On Tuesday, May 19th, Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock. The shares were sold at an average price of $156.61, for a total transaction of $1,864,128.83.
• On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The shares were sold at an average price of $152.02, for a total transaction of $1,792,315.80.
• On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The stock was sold at an average price of $153.65, for a total transaction of $2,402,625.05.

Globe Life Price Performance

GL stock traded up $2.96 during trading on Thursday, reaching $182.65. The company’s stock had a trading volume of 759,810 shares, compared to its average volume of 566,665. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. The company’s fifty day moving average is $170.49 and its 200-day moving average is $153.78. The company has a market capitalization of $14.18 billion, a P/E ratio of 12.13 and a beta of 0.47. Globe Life Inc. has a 1 year low of $127.85 and a 1 year high of $191.55.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The business’s revenue was up 8.0% on a year-over-year basis. During the same period last year, the company earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, research analysts expect that Globe Life Inc. will post 15.73 earnings per share for the current fiscal year.

Institutional Trading of Globe Life

A number of large investors have recently added to or reduced their stakes in the company. Hilton Head Capital Partners LLC purchased a new stake in shares of Globe Life during the 4th quarter worth approximately $30,000. CYBER HORNET ETFs LLC purchased a new position in shares of Globe Life in the second quarter valued at $28,000. MUFG Securities EMEA plc bought a new stake in Globe Life in the second quarter worth $31,000. Torren Management LLC purchased a new stake in Globe Life during the fourth quarter valued at $37,000. Finally, AdvisorNet Financial Inc raised its stake in Globe Life by 41.1% during the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after purchasing an additional 92 shares in the last quarter. Institutional investors own 81.61% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on GL. TD Cowen upped their price target on Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. Keefe, Bruyette & Woods lowered their target price on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday, July 24th. Jefferies Financial Group upped their target price on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. Truist Financial raised their target price on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. Finally, Weiss Ratings downgraded shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $191.67.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.